Your session is about to expire
← Back to Search
Other
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
N/A
Waitlist Available
Led By Anita Moon-Grady, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up birth to 30 months
Awards & highlights
No Placebo-Only Group
Summary
This trial found that for fetuses with severe aortic stenosis, in utero balloon aortic valvuloplasty may improve fetal growth of left heart structures.
Eligible Conditions
- Hypoplastic Left Heart Syndrome
- Aortic Stenosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ monthly until birth, and after birth until three years of age
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~monthly until birth, and after birth until three years of age
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Improved fetal mitral valve and left ventricular growth
Other study objectives
Neurodevelopmental and functional status
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Fetal Aortic ValvuloplastyExperimental Treatment1 Intervention
Subjects will undergo fetal aortic valvuloplasty
Group II: ControlActive Control1 Intervention
Control group. Will receive standard prenatal and postnatal care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fetal Aortic Valvuloplasty
2012
N/A
~10
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,901,763 Total Patients Enrolled
2 Trials studying Hypoplastic Left Heart Syndrome
84 Patients Enrolled for Hypoplastic Left Heart Syndrome
Anita Moon-Grady, MDPrincipal InvestigatorUniversity of California, San Francisco